Skip to main content
OpenTrials
Completed

NCT Number: NCT02028273

Hippocampal Neurogenesis in Human Subjects

This study is being done to measure the number of brain cells that grow in the brain throughout our lives while determining an effective way to complete this with an MRI (Magnetic Resonance Imaging) scanner. The number of these brain cells may be affected by cocaine use. Researchers are trying to understand the long-term effects of cocaine use on the brain.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–55 year

Sex eligibility

All sexes

Study type

Observational

Primary location

UT Southwestern Medical Center at Dallas, Division on Addictions

Dallas, Texas, 75390-8564, United States

About this study

New neurons are generated through the process of neurogenesis. Although most active during pre-natal development, neurogenesis persists throughout the human lifespan. In adulthood, neurogenesis occurs predominantly in the subgranular zone of the hippocampal dentate gyrus. A highly novel methodology using Magnetic Resonance Spectroscopy (MRS) has recently been developed to measure the formation of hippocampal newborn stem cells in the human brain. We propose to assess Neural Progenitor Cells (NPCs) in the neuropsychiatric disorder cocaine dependence, a chronic disease process associated with pathology of the hippocampus and impaired neurogenesis. In addition, we will assess other measures associated with neurogenesis, including hippocampal (dentate gyrus) cerebral blood volume (CBV) using Vascular-Space-Occupancy (VASO) Magnetic Resonance Imaging. We predict that newborn hippocampal cells [or neuronal progenitor cells (NPCs] will be attenuated in recently using cocaine-addicted participants relative to abstinent and control participants, and that these changes will be paralleled by changes in CBV. In this pilot study, we will assess for these changes in cocaine-addicted subjects who are actively using cocaine and those who are recently abstinent (three to six months) as well as age-, race-, and gender-similar control participants.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Cocaine-dependence (patient population) or no cocaine-dependence (control population)

Exclusion criteria

  • Other medical or psychiatric disorders that may effect neural functioning
  • Medications that may effect neural functioning

Treatment and study plan

Primary outcomes

  1. Assess Neural Progenitor Cells

    Time frame: within 3 weeks of screening physical

    A 1 hour Magnetic Resonance Spectroscopy to determine the presence of newborn hippocampal neurons in using and abstinent cocaine addicts

Secondary outcomes

  1. Hippocampal cerebral blood volume

    Time frame: within 3 weeks of screening physical

    Measure cerebral blood flow during an hour long Vascular-Space-Occupancy (VASO) Magnetic Resonance Imaging to assess production of hippocampal cells

Sponsors and collaborators

Lead sponsor

University of Texas Southwestern Medical Center

Other

Registry information

Official study title

Hippocampal Neurogenesis in Human Subjects (Pilot Study)

Acronym: NG

Important dates

Study start
2012
Primary completion
2018
Study completion
2018
First posted
Jan 7, 2014
Registry last updated
Sep 9, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.